
MANE vs GRFS
$MANE vs $GRFS head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
MANE vs GRFS: the quick read
- ·MANE is the larger company by market cap ($4.88B vs $1.91B).
- ·MANE has been more active on our scanner (88 vs 23 alerts in 30 days).
- ·MANE has the smaller float (27.9M vs 680.6M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·GRFS trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·MANE draws far more of our scanner's attention, 88 unusual-volume alerts in 30 days against 23, so it is the more actively traded of the two by some distance.
- ·They have diverged badly over the year: MANE is near the top of its 52-week range while GRFS is near the bottom of its own.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing MANE and GRFS on TheDesperateTrader.
- Is MANE or GRFS the better stock?
- "Better" depends on your goal, and these two are not alike. MANE is the larger company by market cap ($4.88B vs $1.91B). MANE has been more active on our scanner (88 vs 23 alerts in 30 days). MANE has the smaller float (27.9M vs 680.6M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between MANE and GRFS?
- The differences that matter: they are not in the same business - MANE is pharmaceutical preparations and GRFS is pharmaceutical preparations; they are similar in size ($4.88B vs $1.91B); they trade at very different share prices ($116.76 vs $7.31); MANE sits at 85% of its 52-week range against 11% for GRFS; our scanner flagged MANE 88 times in the last 30 days against 23 for GRFS. Everything above is measured from the latest completed session and SEC filings.
- Which of MANE and GRFS is more active right now?
- Right now MANE is at about 0.9x its normal volume and GRFS is at about 0.7x, so MANE is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading MANE or GRFS? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore MANE and GRFS comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.